Vice-Chairman of the Supervisory Board
medicine
HTL-STREFA
Poland
Heinz Norbert Ferdinand Maria von Prondzynski studied mathematics and geography at the Westfälische Wilhelms University.Mr. von Prondzynski held the positions of a CEO in Bayer Diagnostics AG from 1989 to 1996, of the President & CEO in Chiron Corporation, Chiron Behring GmbH, Chiron S.A. from 1996 to 2000 and subsequently of a CEO in F. Hoffmann La Roche Ltd, Div. Diagnostics from 2000 to 2006.Currently, Mr. von Prondzynski is a Member of the Supervisory Board in Royal Philips from 2007, a Chairman of the Board of Directors in Epigenomics AG from 2012 and Independent Lead Director of Quotient Ltd from 2014.Mr. von Prondzynski is the Vice-Chairman of the Supervisory Board in HTL-Strefa S.A. as well as a member of Audit Committee.
Heino Von Prondzynski has broad interests in medicine and research thus far has focused on Medical Diagnostics.